The development and in-vitro evaluation of novel mixed metal hydroxy-carbonate compounds as phosphate binders

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 3, 2001, Pages 361-369

  Rankin, B J ^a   Zhu, H ^a   Webb, M ^b   Roberts, N B ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Crosfield Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; CALCIUM; CARBONIC ACID DERIVATIVE; HYDROTALCITE; MAGNESIUM; METAL COMPLEX; PHOSPHATE BINDING AGENT;

ANALYTIC METHOD; ARTICLE; BINDING KINETICS; CALCIUM ABSORPTION; CHRONIC KIDNEY FAILURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIARRHEA; DRUG MIXTURE; DRUG SYNTHESIS; FOOD DRUG INTERACTION; HUMAN; HYDRATION; IN VITRO STUDY; PH MEASUREMENT; PRECIPITATION;

ALUMINUM; CALCIUM; DESICCATION; FOOD ANALYSIS; IRON; METALS; PHOSPHATES; SOLUTIONS;

EID: 0035097448     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011775596     Document Type: Article

References (25)

1. The dialysis encephalopathy syndrome: Possible aluminium intoxication
2. First data analysis from the UK national renal registry pilot project
3. Chemistry between the sheets
4. Aluminium and dialysis bone disease
5. Accumulation of aluminium in patients with acute renal failure
6. Lanthanum carbonate an effective inhibitor of phosphate absorption from the intestinal tract
7. Management of hyperphosphataemia in patients with renal failure
8. Effect of Rena Gel (20) a non-absorbed calcium and aluminium free phosphate binder on serum phosphorus, calcium and intact parathyroid hormone in end-stage renal disease patients
9. The use of magnesium-containing phosphate binders in patients with end stage renal disease on maintenance haemodialysis
10. Rapid communication. Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients
11. Kinetic fluorimetric determination of aluminium in serum
12. Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach
13. Hyperphosphataemia and hypophosphataemia
14. Renal osteodystrophy
15. Substitution of aluminium salts in control of dialysis hyperphospahtaemia
16. Reversal of aluminium induced haemodialysis anaemia by low aluminium dialysate
17. Long term use of magnesium hydroxide as a phosphate binder in patients on haemodialysis
18. Hydrotalcites as potential absorbents of intestinal phosphate
19. The chemistry of aluminium in the gastrointestinal tract and it's uptake and absorption
20. Investigations into new phosphate binders
21. Synthesis of anionic clay minerals (mixed metal hydroxides, hydrotalcite)
22. Haematologic consequences of renal failure
23. Phosphate control and 25-hydroxy-cholecalciferol administration in preventing experimental renal osteodystrophy in the dog
24. Aluminium accumulation during treatment with aluminium hydroxide and dialysis in children and young adults with renal disease
25. Treatment of uremic hyperphosphataemia - Is there still a need for aluminium salts